Adverse pregnancy and maternal outcomes in women with hidradenitis suppurativa - 02/07/21
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background |
Hidradenitis suppurativa (HS) disproportionately affects women of childbearing age. However, pregnancy and maternal outcomes for women with HS are unknown.
Objective |
To compare risk of adverse pregnancy and maternal outcomes among women with and without HS and to evaluate the influence of comorbid conditions.
Methods |
Retrospective cohort analysis between January 1, 2011, and September 30, 2015.
Results |
Compared to control pregnancies (n = 64,218), HS pregnancies (n = 1862) had a higher risk of spontaneous abortion (15.5% vs 11.3%), preterm birth (9.1% vs 6.7%), gestational diabetes mellitus (11.6% vs 8.4%), gestational hypertension (6.1% vs 4.4%), preeclampsia (6.6% vs 3.8%), and cesarean section (32.4% vs 27.1%). Relative risk of some pregnancy and maternal outcomes were attenuated after comorbidity adjustment. In the fully adjusted model, HS pregnancies were independently associated with spontaneous abortion (odds ratio, 1.20; 95% CI, 1.04-1.38), gestational diabetes mellitus (odds ratio, 1.26; 95% CI, 1.07-1.48), and cesarean section (odds ratio, 1.09; 95% CI, 1.004-1.17).
Limitations |
We could not evaluate potential influences of disease duration, activity, or severity. Newborn outcomes could not be evaluated.
Conclusion |
HS appears to be an independent risk factor for adverse pregnancy and maternal outcomes. This risk is influenced by comorbidities that may be modifiable with early identification and management.
Le texte complet de cet article est disponible en PDF.Key words : epidemiology, Explorys, hidradenitis suppurativa, maternal, outcomes, pregnancy, women
Abbreviations used : HS, ICD, LMP, OR
Plan
Drs Fitzpatrick and Hsiao contributed equally to this work. |
|
Funding sources: This study was supported in part by an education grant from AbbVie. The sponsor has had no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. |
|
An earlier analysis was presented at the 10th Conference of the European Hidradenitis Suppurativa Foundation e.V., Virtual meeting, February 10-12, 2021. |
|
IRB approval status: Approved by the human subjects committee at the Feinstein Institute for Medical Research at the Northwell Health. |
|
Reprints not available from the authors. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?